Riskpilot← Back to searchSign inGet full accessCrispatus Oy
OYActiveY-tunnus 3021107-9Wavulinintie 3-B32Medical specialists activities · NACE 8622Est. 20191 employees
Revenue 2025
EUR 0
EBITDA margin
—
-187% vs 2024
Equity ratio
99.6%
Financial strength
Net profit 2025
EUR 77K
+10% vs 2024
| Revenue | EUR 0 | — |
| EBITDA | EUR -86K | -187% |
| Net profit | EUR 77K | +10% |
| Total assets | EUR 261K | +20% |
| Equity | EUR 260K | +20% |
| Employees | 1 | — |
Legal name
Crispatus Oy
Y-tunnus number
3021107-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
28. elokuuta 2019
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
terveyspalvelujen tuottaminen väestölle, sisältäen mm. lääkärinpalvelut, lääketieteellinen konsultointi, koulutus ja tutkimus; sekä ostaa, myydä ja hallinnoida arvopapereita ja kiinteistöjä.
Address
Wavulinintie 3-B32
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 164 | 205 | 0 | 199 | 0 |
| Staff expenses | −68 | −89 | −670 | −26 | −13 |
| EBITDA | 49 | 49 | 0 | 99 | −86 |
| Depreciation & amort. | — | −17 | −1 239 | −11 | −9 |
| EBIT | 49 | 32 | 53 | 87 | −95 |
| Net financials | −0 | −0 | 0 | −0 | 0 |
| Profit before tax | 49 | 32 | 0 | 87 | 77 |
| Tax | 10 | 6 | −0 | 17 | −0 |
| Net profit | 39 | 26 | 42 | 70 | 77 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 112 | 152 | 160 | 217 | 261 |
| Equity | 110 | 127 | 159 | 216 | 260 |
| Long-term debt | — | 23 | 0 | 0 | 0 |
| Short-term debt | 2 | 3 | 1 | 1 | 1 |
| Total debt | 2 | 25 | 1 | 1 | 1 |
EBITDA margin
-8614300.0%
This company
15.8%
Market median
-54520986% vs market
20212025
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
29.6%
This company
18.4%
Market median
+61% vs market
20212025
Net profit margin
7690800.0%
This company
8.1%
Market median
+94948048% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
PT Chief Executive Officer | Chief Executive Officer | 2019 |
TT | Audit | 2024 |
NE Deputy Member | Deputy Member | 2019 |
VJ Deputy auditor | Deputy auditor | 2024 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Crispatus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Päivi Tiina Helena Tommola | Chief Executive Officer | 0 companies |
| Tarja Tuulikki Tolvanen | Audit | 0 companies |
| Nea Erika Rossi | Deputy Member | 0 companies |
| Virve Janniina Haavisto | Deputy auditor | 0 companies |